The minimally invasive, first-line treatment for Stress Urinary Incontinence (SUI) in women. SUI is characterized by the involuntary leakage of urine, typically upon exercise, coughing or sneezing. It is a common condition that may affect up to 25% of adult women.
Deflux for SUI is available in Canada and Europe. Deflux for SUI is not available for commercial sale in the United States.